Suppr超能文献

吡啶斯的明:小儿麻痹后遗症综合征。

Pyridostigmine: Postpoliomyelitis Syndrome.

作者信息

Generali Joyce A, Cada Dennis J

出版信息

Hosp Pharm. 2016 May;51(5):367-9. doi: 10.1310/hpj5105-367.

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

摘要

本医院药学特色内容摘自《药品未标示用途事实》,这是威科医疗出版的一份刊物。《药品未标示用途事实》是一份面向从业者的资源,提供有关美国食品药品监督管理局未批准的特定药物用途的信息。这本新的文献指南使医疗保健专业人员或临床医生能够快速识别关于未标示用途的已发表研究,并确定在患者护理场景中特定用途是否合理。参考文献引导读者查阅完整文献以获取更全面的信息,然后再做出患者护理决策。有关药品未标示用途的问题或意见,请发送至jgeneral@ku.edu

相似文献

1
Pyridostigmine: Postpoliomyelitis Syndrome.
Hosp Pharm. 2016 May;51(5):367-9. doi: 10.1310/hpj5105-367.
2
Rifaximin: irritable bowel syndrome.
Hosp Pharm. 2014 Dec;49(11):1014-6. doi: 10.1310/hpj4911-1014.
3
Amitriptyline: interstitial cystitis (painful bladder syndrome).
Hosp Pharm. 2014 Oct;49(9):809-10. doi: 10.1310/hpj4909-809.
4
Atorvastatin: multiple sclerosis.
Hosp Pharm. 2014 Nov;49(10):920-2. doi: 10.1310/hpj4910-920.
5
Sodium Thiosulfate: Calciphylaxis.
Hosp Pharm. 2015 Nov;50(11):975-7. doi: 10.1310/hpj5011-975. Epub 2015 Nov 24.
6
Montelukast: Chronic Urticaria.
Hosp Pharm. 2015 Jul;50(7):583-5. doi: 10.1310/hpj5007-583. Epub 2015 Jul 31.
7
Ciprofloxacin: Tularemia (Adults).
Hosp Pharm. 2015 Apr;50(4):274-6. doi: 10.1310/hpj5004-274. Epub 2015 Apr 8.
8
Simvastatin: Multiple Sclerosis.
Hosp Pharm. 2015 Jun;50(6):464-6. doi: 10.1310/hpj5006-464.
9
Trazodone: Insomnia (Adults).
Hosp Pharm. 2015 May;50(5):367-9. doi: 10.1310/hpj5005-367.
10
Montelukast: Eosinophilic Esophagitis.
Hosp Pharm. 2016 Jun;51(6):450-1. doi: 10.1310/hpj5106-450.

本文引用的文献

1
Treatment for postpolio syndrome.
Cochrane Database Syst Rev. 2015 May 18;2015(5):CD007818. doi: 10.1002/14651858.CD007818.pub3.
2
Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy.
Ann Phys Rehabil Med. 2010 Feb;53(1):34-41. doi: 10.1016/j.rehab.2009.12.003. Epub 2009 Dec 31.
3
EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force.
Eur J Neurol. 2006 Aug;13(8):795-801. doi: 10.1111/j.1468-1331.2006.01385.x.
4
Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.
J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1655-61. doi: 10.1136/jnnp.74.12.1655.
5
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome.
Neurology. 1999 Oct 12;53(6):1225-33. doi: 10.1212/wnl.53.6.1225.
6
An open trial of pyridostigmine in post-poliomyelitis syndrome.
Can J Neurol Sci. 1995 Aug;22(3):223-7. doi: 10.1017/s0317167100039883.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验